Tuberculosis remains a major health problem worldwide, with 7 million new cases of tuberculosis a year accounting for 400,0)00 deaths (7, 28) . In 1984 in the United States, 22 ,255 cases of tuberculosis resulted in an estimated 2,000 deaths (3) . The occurrence of tuberculosis among patients with acquired immunodeficiency syndrome (AIDS) (4), among the homeless (2) , and among the elderly in nursing homes (24) have all contributed to a rising incidence of the disease in the United States, first noted in 1986. This highlights the need for an improved vaccine against tuberculosis, since vaccination with Mycobacterium bovis BCG is not always effective (1) .
Studies with animal models clearly indicate that resistance to mycobacteria is a cell-mediated process that requires oooperation between thymus-dependent (T) lymphocytes and other cells to be effective (11, 12, 15, 19) . Antibodies alone seem to contribute little to resistance (22) , and activated macrophages appear to be the main effector cells (16, 27) . Genetically determined primary resistance to infection with M. bovis BCG in mice appears to be expressed in the macrophage and may be controlled by a single gene (21) . T cells regulate and maintain the cell-mediated immune response which follows primary exposure and forms the mechanism for acquired resistance. Whether cells capable of eliciting a delayed-type hypersensitivity response are the same as those providing a protective immune response remains an area of controversy.
We have established murine T-cell clones reactive to mycobacterial antigens in order to further investigate the mechanism by which these cells may mediate resistance to experimental tuberculosis infection and to define the antigens which induce protective T cells. T-cell clones which induce protective immunity could subsequently be used to select protective antigens produced by recombinant DNA technology as primary candidates for the development of an improved vaccine for tuberculosis.
ing the crude lysates with the appropriate monoclonal antibodies.
Immunization. H37Ra and H37Rv were emulsified in incomplete Freund adjuvant and injected subcutaneously into all four footpads and at the base of the tail of each C57BL/6 mouse. All of the mice received 400 jig of these antigens.
Establishment of mycobacterium-specific T-cell clones. Tcell cultures were initiated and maintained as described by Kimoto and Fathman (10) and Kaufmann and Hahn (9) with modifications based on the method; of Sheppard et al. (23) .
Single-cell suspensions were prepared from inguinal, axillary, and periaortic lymph nodes harvested from mice immunized 14 days earlier. [3H]TdR (1 ,uCi) was added for the last 6 h, after which the cells were processed as described above. The presence of IL-2 or B-cell stimulatory factor 1 (BSF1) was determined by the method of Lichtman et al. (13) . Briefly, HT-2 cells were incubated with supernatants from T-cell clones with or without either anti-BSF1 antibody (llBl1, 1:1,000 dilution of ascites) or anti-IL-2 receptor (IL2R) antibody (7D4+ PC61, 1:100 dilution of ammonium sulfate-precipitated hybridoma culture supernatants), and the degree of inhibition of TdR incorporation was determined. Both monoclonal antibodies were known to specifically inhibit the response of HT-2 cells to either recombinant IL-2 (Genzyme, Boston, Mass.) or high-pressure-liquid-chromatography-purified BSF1 and recombinant BSF1. The presence of gamma interferon (IFN--y) was assessed by a quantitative assay for the induction of Ia on resting macrophages (26 (Table 2 ). All five H37Rv clones cross-reacted with PPD and H37Ra. Of these, all but one (clone 3H10) recognized BCG (Table 3) .
Surface phenotype of M. tuberculosis-reactive T-cell clones. All of the clones tested by immunofluorescence were found to be Thy-1.2+ Lyt-1.2+ L3T4+ Lyt-2.2-. In all cases, more than 95% of all cells reacted with monoclonal antibodies to the surface antigens.
H-2 restriction of antigen-specific proliferation of M. tuberculosis-reactive T-cell clones. The requirement for histocompatibility of nine T-cell clones and APC was examined in a standard proliferation assay. All of the clones tested responded to their primary antigen presented by APC from C57BL/6, C3H.SW, and B10.A(5R) mice (all I-Ab) and failed to proliferate when APC from BALB/c, B10.A(4R), or B10.MBR mice were used. A representative experiment with three clones is shown in Fig. 1 . As anticipated, these experiments indicate that compatibility at the I-A sublocus of the H-2 complex is sufficient and necessary for effective antigen presentation.
Lymphokine production. Recent data indicate that helper/ inducer T cells fall into two distinct classes on the basis of lymphokine secretion profiles. One secretes BSF1 and the other secretes IL-2 and IFN-y (13) . Because of the potential biologic significance of this distinction, we evaluated the T-cell clones for the production of IL-2, BSF1, and IFN--y.
Supernatants from all nine clones tested could stimulate HT-2 cells. When monoclonal antibodies known to inhibit the response of HT-2 cells to recombinant IL-2 were added to the supernatants from antigen-stimulated T-cell clones, a marked reduction in proliferation was noted (Table 4) . No attenuated HT-2 response was seen when anti-BSF1 antibodies were mixed with culture supernatants. The extent of [3H]TdR incorporation by HT-2 cells incubated with supernatants from T cells cultured without antigen was less than 1,000 cpm. These findings indicate that all of the clones tested produce IL-2 and do not appear to produce detectable levels of BSF1. The controls for these experiments consisted of HT-2 cells incubated with recombinant human IL-2 (20 U/ml) or recombinant murine BSF1 (250 U/ml) with or without the anti-IL2R and anti-BSF1 monoclonal antibodies. Consistently greater than 90% inhibition of [3H]TdR incorporation was observed for each purified lymphokine in the presence of its blocking antibody (13) . The supernatants of clones Gll, B8, and Cl were also tested for the presence of IFN--y by a quantitative method to measure the induction of Ia on resting peritoneal adherent cells of A/J mice. All of the supernatants tested contained Ia-inducing activity. A representative experiment for two clones is shown in Table 5 . Furthermore, the IFN-y activity could be neutralized by the hamster monoclonal antibody specific for murine IFN-y (H22.10.38.22) ( (7a, 29) . We found that three T-cell clones (H1O-PPD, 3H9-H37Rv, and 3F1-H37Rv) recognized the 19-kDa antigen (Y3147) and that one T-cell clone (Gll-PPD) recognized the 65-kDa antigen (Y3143). None of the clones tested recognized the 71-kDa (Y3272) or the 14-kDa (Y3247) antigen. Representative experiments with all four positively reacting and two nonreactive clones (B8 and Cl) are summarized in Table 6 . Crude lysates of E. coli infected with Xgtll alone, without a mycobacterial DNA insert but containing the intact Igalactosidase molecule, gave no significant proliferative responses. Dose-response curves revealed that 5 to 10 ,ug of protein per ml of the crude lysates gave optimal proliferation (results not shown). Larger doses (20 to 50 jig) of the crude recombinant antigen preparations were found to be toxic for the T-cell clones. The presence of toxic or inhibitory factors may partially explain why the maximal response to the recombinant antigens was significantly lower than the maximal response to the primary antigen. With smaller doses (1 to 10 ,ug), nonspecific mitogenic effects were occasionally observed. Because the 65-kDa antigens of M. tuberculosis and M. leprae contain cross-reacting epitopes identified by monoclonal antibodies (7a), we tested the ability of clone Gll to proliferate in response to the 65-kDa M. leprae antigen. Clone Gll proliferated in response to the 65-kDa antigen of M. leprae (Table 7) , although not as strongly as to the 65-kDa M. tuberculosis antigen. Negative controls in this experiment included Agtll alone and the 71-kDa antigen of M. tuberculosis, Y3272, which was previously found to be nonreactive. These results indicate that the 65-kDa antigens of M. tuberculosis and M. leprae also share cross-reactive epitopes recognized by T cells.
Local transfer of DTH reactions. To determine the ability immunological memory was measured by rechallenging all of the footpads with PPD 5 to 6 days after the initial transfer. The pattern on rechallenge was similar to the pattern observed on primary transfer. It is interesting that a DTH response developed in footpads previously injected with T cells alone on local challenge with antigen 5 to 6 days later, suggesting prolonged viability of the unstimulated T cells upon local transfer (data not shown).
DISCUSSION
The purpose of this study was to generate a panel of T-cell clones reactive to M. tuberculosis and to evaluate their in vitro and in vivo characteristics. By using both whole mycobacteria and PPD as primary antigens, we obtained 17 T-cell clones that were markedly heterogeneous in their response to four crude mycobacterial antigen preparations (PPD, BCG, H37Ra, and H37Rv). Although all of the clones reacted to various degrees to M. tuberculosis PPD, two clones (3H10 and G3) were able to differentiate BCG from H37Rv or H37Ra when whole bacteria were used as the antigen. In addition, three clones (Fl, G3, and F3) proliferated strongly in response to H37Ra, but poorly or not at all in response to H37Rv. This may simply reflect the manner in which these antigens were prepared: heat-killed H37Ra versus paraformaldehyde-treated H37Rv and BCG. Lyophilization alone does not appear to change the antigenic constituents much, because when lyophilized paraformalde- hyde-treated BCG was used, clone 3H10 was still unable to recognize BCG (data not shown). These findings, however, also raise the possibility that T cells recognize significant antigenic differences between H37Ra and H37Rv, as well as differences between H37Ra/H37Rv and BCG. However, Kaufmann and Fleisch (8) recently found that none of the L3T4+ T-cell clones from H37Rv-immunized mice was able to distinguish among BCG, H37Rv, and H37Ra. All six of the clones examined in their study reacted to PPD. The antigen preparations used by these researchers were very similar to the ones used in the present study (8) . In (7a) . Our study represents the first report of murine T-cell clones which respond to some of the recombinant antigens isolated with monoclonal antibodies from expression libraries of M. tuberculosis and M. leprae.
The significance of the 65-kDa antigen of M. tuberculosis in human disease remains to be established. However, several lines of evidence suggest that it may be an important immunodominant antigen. First, antibodies to a 65-kDa antigen are present in the sera of patients with tuberculosis (25) . From our studies and those of others, it is clear that a 65-kDa molecule is present in PPD (25) . In addition, human helper T-cell clones isolated from patients with M. tuberculosis infections recognize the same recombinant 19-and 65-kDa antigens as the murine T-cell clones described here (17) . Finally, a human T-cell clone derived from a patient with tuberculoid leprosy responds to a 64-kDa recombinant antigen of M. bovis BCG (6) . These findings all suggest that the 65-kDa protein is a major mycobacterial antigen which is highly conserved across mycobacterial species and appears to carry many cross-reactive epitopes.
All of the cloned T cells tested carry the Thy-1+ Lyt-1+ L3T4+ Lyt-2-phenotype of helper T cells and proliferate only when antigen is presented by APC that are histocompatible at the I-A locus of the H-2 complex. All of the clones tested appear to belong to the subset of helper T cells that secrete IL-2 and IFN--y but not BSF1 (13) . Consistent with this finding is the ability of the clones to mediate DTH in vivo, for which both IL-2 and IFN--y, as macrophageactivating factors, may be important mediators. It is not yet definitively established whether the helper function for B cells correlates with profiles of lymphokine secretion. However, it is reasonable to postulate that IL-2-and IFN--ysecreting helper T cells play a dominant role in cell-mediated immunity and that these are the lymphokines produced by the M. tuberculosis-reactive clones that we have generated.
All of the nine T-cell clones tested were able to transfer DTH locally. Clones could be differentiated on the basis of the degree of swelling observed in the footpads and the minimum number of cells necessary to elicit a DTH response. Pedrazzini and Louis (20) recently described a number of T-cell clones specific for PPD and BCG, some of which could not transfer DTH even when 106 cells were transferred. We did not observe this with the clones we developed. This may be the result of different selection pressures caused by different cloning strategies. Our clones were derived from long-term lines, whereas Pedrazzini and Louis (20) cloned their cells soon after isolating T cells from immunized mice.
We have thus demonstrated that despite similar abilities to produce lymphokine and transfer DTH, the helper/inducer T-cell clones recognize a diversity of mycobacterial antigens within the context of I-A histocompatible APC. It may be possible to differentiate clones by their capacity to inhibit the growth of M. tuberculosis. Studies to evaluate the ability of the M. tuberculosis-responsive T-cell clones described here to inhibit local growth of virulent M. tuberculosis are under way. T-cell clones may therefore be useful for the identification of potentially important antigens of M. tuberculosis obtained by recombinant DNA technology or by other means. A recent report by Orme (18) raises the possibility that different populations of protective T cells are generated during the course of M. tuberculosis infection in mice. These different populations may have different dominant antigenic specificities. This could make it more difficult to define protective antigens with T-cell clones derived from animals immunized with killed mycobacteria (18) .
